M Mottolese Selected Research

M Mottolese Research Topics

Disease

22	Neoplasms (Cancer) 08/2015 - 03/2000
18	Breast Neoplasms (Breast Cancer) 02/2016 - 03/2000
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 08/2015 - 09/2003
3	Colorectal Neoplasms (Colorectal Cancer) 07/2012 - 09/2001
3	Neoplasm Metastasis (Metastasis) 11/2010 - 04/2000
2	Testicular Neoplasms (Testicular Cancer) 08/2010 - 04/2009
2	Carcinoma (Carcinomatosis) 11/2004 - 08/2000
2	Endometrial Neoplasms (Endometrial Cancer) 06/2003 - 02/2000
2	Ovarian Neoplasms (Ovarian Cancer) 05/2002 - 05/2001
1	Adenocarcinoma 08/2015
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 08/2015
1	Lung Neoplasms (Lung Cancer) 08/2015
1	Ataxia Telangiectasia (Louis Bar Syndrome) 02/2014
1	Necrosis 02/2014
1	Disease Progression 07/2012
1	Brain Neoplasms (Brain Tumor) 03/2011
1	Seminoma 08/2010
1	Pancreatic Neoplasms (Pancreatic Cancer) 02/2010
1	Cardiotoxicity 11/2008
1	Mucinous Adenocarcinoma (Mucinous Carcinoma) 06/2008
1	Melanoma (Melanoma, Malignant) 03/2007
1	Multiple Myeloma 01/2006
1	Rectal Neoplasms (Rectal Cancer) 11/2004
1	Aneuploidy (Aneuploid) 09/2001
1	Lymphatic Metastasis 05/2001
1	Carcinogenesis 05/2000
1	Hypoxia (Hypoxemia) 04/2000

Drug/Important Bio-Agent (IBA)

9	Proteins (Proteins, Gene)FDA Link 02/2016 - 04/2000
6	ErbB Receptors (EGF Receptor)IBA 02/2016 - 05/2001
4	Monoclonal AntibodiesIBA 06/2003 - 02/2000
3	Estrogens (Estrogen)FDA Link 09/2012 - 12/2000
3	Fluorouracil (Carac)FDA LinkGeneric 11/2010 - 09/2001
3	Messenger RNA (mRNA)IBA 08/2010 - 04/2000
3	Trastuzumab (Herceptin)FDA Link 01/2010 - 04/2006
3	Progesterone Receptors (Progesterone Receptor)IBA 10/2008 - 12/2000
3	DNA (Deoxyribonucleic Acid)IBA 06/2008 - 09/2001
2	Tyrosine Kinase InhibitorsIBA 08/2015 - 09/2003
2	Biomarkers (Surrogate Marker)IBA 08/2015 - 05/2000
2	Docetaxel (Taxotere)FDA Link 05/2012 - 11/2008
2	AnthracyclinesIBA 11/2008 - 12/2000
2	Oncogene Proteins (Oncogene Protein)IBA 06/2003 - 05/2001
2	ParaffinIBA 06/2003 - 05/2001
1	Protein Isoforms (Isoforms)IBA 02/2016
1	SuspensionsIBA 08/2015
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 08/2015
1	Phenobarbital (Luminal)FDA Link 09/2014
1	NectinsIBA 09/2014
1	Proteasome Endopeptidase Complex (Proteasome)IBA 02/2014
1	Ligases (Synthetase)IBA 02/2014
1	Phosphotransferases (Kinase)IBA 02/2014
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 12/2012
1	Liposomes (Liposome)IBA 12/2012
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 09/2012
1	Estrogen Receptor betaIBA 09/2012
1	MicroRNAs (MicroRNA)IBA 09/2012
1	Hormones (Hormone)IBA 09/2012
1	Transcription Factors (Transcription Factor)IBA 09/2012
1	Glucose (Dextrose)FDA LinkGeneric 07/2012
1	Epirubicin (Ellence)FDA LinkGeneric 05/2012
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 05/2012
1	Capecitabine (Xeloda)FDA Link 03/2011
1	Lapatinib (GW572016)FDA Link 03/2011
1	Leucovorin (Folinic Acid)FDA Link 11/2010
1	Irinotecan (Camptosar)FDA LinkGeneric 11/2010
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 11/2010
1	Cetuximab (Erbitux)FDA Link 11/2010
1	Aurora KinasesIBA 08/2010
1	Gemcitabine FDA Link 02/2010
1	DNA Repair EnzymesIBA 02/2010
1	Ribonucleotide Reductases (Ribonucleotide Reductase)IBA 02/2010
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2010
1	Phosphatidylinositols (Phosphatidylinositol)IBA 01/2010
1	Taxoids (Taxanes)IBA 10/2008
1	SurvivinIBA 05/2008
1	Tumor Biomarkers (Tumor Markers)IBA 05/2008
1	Coloring Agents (Dyes)IBA 03/2007
1	thiamine triphosphorate (TTP)IBA 04/2006
1	Vinorelbine (Navelbine)FDA LinkGeneric 04/2006
1	Becaplermin (PDGF-BB)FDA Link 01/2006
1	Melphalan (Alkeran)FDA LinkGeneric 01/2006
1	CytokinesIBA 01/2006
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2006
1	Gefitinib (Iressa)FDA Link 09/2003
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 05/2002
1	Indicators and Reagents (Reagents)IBA 05/2001
1	Glycoproteins (Glycoprotein)IBA 05/2001
1	HLA-A2 Antigen (HLA A2 Antigen)IBA 05/2001
1	Peptides (Polypeptides)IBA 05/2001
1	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 05/2001
1	AntibodiesIBA 05/2001
1	IntegrinsIBA 08/2000
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 08/2000
1	Doxorubicin (Adriamycin)FDA LinkGeneric 04/2000
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2000
1	AntigensIBA 03/2000

Therapy/Procedure

12	Therapeutics 02/2016 - 12/2000
7	Drug Therapy (Chemotherapy) 08/2015 - 12/2000
2	Neoadjuvant Therapy 11/2010 - 11/2004
1	Aftercare (After-Treatment) 08/2015
1	Adjuvant Chemotherapy 05/2012